Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

The association of co-expression of CD44v4/MMP-9 with different nodal status in high-grade breast carcinoma patients.

Thanakit V, Sampatanukul P, Ruangvejvorachai P, Keelawat S.

J Med Assoc Thai. 2005 Sep;88 Suppl 4:S30-5.

PMID:
16622998
3.

[Relationship between lymph node metastasis and the expressions of E-cadherin, N-cadherin, and matrix metalloproteinase in breast carcinoma].

Wang LH, Liu DY, Chen YJ, Hou L, Wang B, Mao LM, Lu S.

Ai Zheng. 2002 Sep;21(9):965-9. Chinese.

PMID:
12508543
4.

Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer.

Shah FD, Shukla SN, Shah PM, Shukla HK, Patel PS.

Indian J Cancer. 2009 Jul-Sep;46(3):194-202. doi: 10.4103/0019-509X.52953.

5.

MMP-2 positivity and age less than 40 years increases the risk for recurrence in premenopausal patients with node-positive breast carcinoma.

Talvensaari-Mattila A, Pääkkö P, Turpeenniemi-Hujanen T.

Breast Cancer Res Treat. 1999 Dec;58(3):287-93.

PMID:
10718490
6.

The expression of matrix metalloproteinase 9 and cathepsin B in gastric carcinoma is associated with lymph node metastasis, but not with postoperative survival.

Czyzewska J, Guzińska-Ustymowicz K, Kemona A, Bandurski R.

Folia Histochem Cytobiol. 2008;46(1):57-64. doi: 10.2478/v10042-008-0007-6.

7.

Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer.

Hao L, Zhang C, Qiu Y, Wang L, Luo Y, Jin M, Zhang Y, Guo TB, Matsushima K, Zhang Y.

Cancer Lett. 2007 Aug 8;253(1):34-42. Epub 2007 Feb 16.

PMID:
17306924
8.

CD44 expression and axillary lymph node metastasis in infiltrating ductal carcinoma of the breast.

Looi LM, Cheah PL, Zhao W, Ng MH, Yip CH.

Malays J Pathol. 2006 Dec;28(2):83-6.

9.

Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy.

Bartlett JM, Ellis IO, Dowsett M, Mallon EA, Cameron DA, Johnston S, Hall E, A'Hern R, Peckitt C, Bliss JM, Johnson L, Barrett-Lee P, Ellis P.

J Clin Oncol. 2007 Oct 1;25(28):4423-30.

11.

Breast carcinoma grading, estimation of tumor size, axillary lymph node status, staging, and nottingham prognostic index scoring on mastectomy specimens.

Ahmad Z, Khurshid A, Qureshi A, Idress R, Asghar N, Kayani N.

Indian J Pathol Microbiol. 2009 Oct-Dec;52(4):477-81. doi: 10.4103/0377-4929.56123.

12.

Expression of nm23, MMP-2, TIMP-2 in breast neoplasm in Zhengzhou Center Hospital, China.

Peihong S, Perry F.

Ethiop Med J. 2007 Jan;45(1):79-83.

PMID:
17642161
13.

CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer.

Okayama H, Kumamoto K, Saitou K, Hayase S, Kofunato Y, Sato Y, Miyamoto K, Nakamura I, Ohki S, Sekikawa K, Takenoshita S.

Oncol Rep. 2009 Oct;22(4):745-55.

PMID:
19724852
14.

Expression of gelatinase (MMP-2 and MMP-9) and cyclooxygenase-2 (COX-2) in endometrial carcinoma.

Karahan N, Güney M, Baspinar S, Oral B, Kapucuoglu N, Mungan T.

Eur J Gynaecol Oncol. 2007;28(3):184-8.

PMID:
17624083
15.

Expression of matrix metalloproteinase 9 in pancreatic ductal carcinoma is associated with tumor metastasis formation.

Pryczynicz A, Guzińska-Ustymowicz K, Dymicka-Piekarska V, Czyzewska J, Kemona A.

Folia Histochem Cytobiol. 2007;45(1):37-40.

16.

CD44 crosslinking-mediated matrix metalloproteinase-9 relocation in breast tumor cells leads to enhanced metastasis.

Peng ST, Su CH, Kuo CC, Shaw CF, Wang HS.

Int J Oncol. 2007 Nov;31(5):1119-26.

PMID:
17912438
17.

Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade.

Makretsov NA, Hayes M, Carter BA, Dabiri S, Gilks CB, Huntsman DG.

Mod Pathol. 2007 Jan;20(1):84-9. Epub 2006 Nov 24.

18.

Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.

Unsal D, Akyurek N, Uner A, Erpolat OP, Han U, Akmansu M, Mentes BB, Dursun A.

Am J Clin Oncol. 2008 Feb;31(1):55-63. doi: 10.1097/COC.0b013e318068b4e2.

PMID:
18376229
19.

Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas.

Zhang YG, DU J, Tian XX, Zhong YF, Fang WG.

Chin Med J (Engl). 2007 Sep 20;120(18):1597-605.

PMID:
17908479
20.

Matrix metalloproteinase-9 activity is associated with poor prognosis in T3-T4 node-negative colorectal cancer.

Cho YB, Lee WY, Song SY, Shin HJ, Yun SH, Chun HK.

Hum Pathol. 2007 Nov;38(11):1603-10. Epub 2007 Jul 31.

PMID:
17669467
Items per page

Supplemental Content

Write to the Help Desk